K820391

Substantially Equivalent

ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI

Applicant: Hoffmann-La Roche, Inc.
Product code: LAT
Advisory panel: Clinical Toxicology
Date received: 1982-02-10
Decision date: 1982-03-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.